JAMA highlights IGNITE sites’ work to integrate genomic testing in routine care

Journal of the American Medical Association – University of Maryland’s Dr. Toni Pollin and Duke University’s Drs. Geoff Ginsburg and Lori Orlando discuss how their programs are working to improve care through genetic testing in areas such as diagnosing monogenic diabetes and using family history to identify patients’ personal disease risks.

0 comments

IGNITE Network analysis of challenges to implementing genomics in practice featured on GenomeWeb

GenomeWeb – Duke University led this effort to identify key challenges to and potential solutions for implementing genomics in practice based on information from IGNITE’s six member projects. (A free subscription is required to view this article.)

0 comments

IGNITE Network highlighted at Precision Medicine World Conference 2017

BioQuick News – Duke University’s Dr. Geoffrey Ginsburg, co-chair and speaker at the 2017 Precision Medicine World Conference, presented the IGNITE Network’s achievements and aspirations to advance the implementation of genomics in practice.

0 comments

IGNITE sites present at the 2017 Genomic Medicine X: PGx Meeting

IGNITE’s Drs. Todd Skaar, Josh Denny, Larisa Cavallari, and Kristin Weitzel were session speakers at the Genomic Medicine X: Research Directions in Pharmacogenomics Implementation Meeting on May 2 -3, 2017.

0 comments

University of Maryland offers genomics education course using students’ own genomes

Association of American Medical Colleges – To help future clinicians better understand the importance of using genomics in practice, University of Maryland College of Medicine students can choose to study parts of their own genomes, or anonymous genomes, in a course all medical students are required to take.

0 comments

IGNITE Network’s Kristin Weitzel quoted in AAMC story on the growth of genetics in medical education

Association of American Medical Colleges – Dr. Kristin Weitzel of the UF Health Personalized Medicine Program outlines the benefits and challenges of training medical students to use genetic information in clinical practice.

0 comments

University of Maryland incorporates pharmacogenomic testing in routine care for stent patients

The Baltimore Sun – Researchers and clinicians at the University of Maryland worked together to make CYP2C19 testing routine for stent patients, reducing the rate of adverse events such as death, heart attack, and stroke.

0 comments

Sanford Heart Hospital develops routine pharmacogenetic testing process for cardiac patients

Keloland Media Group – Sanford Heart Hospital uses genetic testing to determine if clopidogrel is an effective blood thinner for its cardiac patients, an effort aided in part by work completed by IGNITE’s Dissemination, Outreach, and Sustainability Working Group.

0 comments

Essentia Health promotes MeTree, a family health history tool developed by Duke University

Essential Health Daily Dose – In order to gain a better understanding of their personal health risks, Essentia Health encourages employees to use Thanksgiving as an opportunity to complete a family health history using Duke University’s MeTree tool.

0 comments

Vanderbilt University receives historic NIH grant to become part of a prestigious national precision medicine program

VUMC Reporter – Vanderbilt University will serve as the Data and Research Support Center for the Precision Medicine Initiative Cohort Program with a five year, $71.6 million NIH grant, the largest of its kind Vanderbilt has received to date.

0 comments

IGNITE researchers collaborate to improve patient outcomes through genomics

A collaborative IGNITE Network study shows that a quick, precise genetic test can significantly reduce the risk of cardiovascular events by helping to identify more effective medication for some heart patients. University of Florida researcher Larisa Cavallari, Pharm.D., presented these findings at the American Heart Association Scientific Sessions on Nov. 15, 2016.

0 comments

University of Florida’s work on genetic testing to prevent complications for cardiac patients featured in Explore Magazine

Explore Magazine – IGNITE’s Dr. Julie Johnson explains the impact of translating the UF Health Personalized Medicine Program’s research on gene-drug responses to clopidogrel into a standard practice for interventional cardiology patients at UF Health.

0 comments

IGNITE Network highlighted in the Journal of the American Medical Association

Journal of the American Medical Association – Duke University’s Dr. Geoffrey Ginsburg and University of Florida’s Dr. Julie Johnson discuss the value of and challenges facing the use of pharmacogenomics to improve patient care.

0 comments

The Gainesville Sun spotlights the history and accomplishments of the UF Health Personalized Medicine Program

The Gainesville Sun – The University of Florida’s Dr. Julie Johnson and Dr. Larisa Cavallari discuss the trail the IGNITE Network’s UF Health Personalized Medicine Program has blazed in the field of precision medicine since its founding.

0 comments

Duke University study uncovers clues as to how aspirin may help prevent colon cancer

The Duke Chronicle – Dr. Geoffrey Ginsburg of the Duke Center for Applied Genomics and Precision Medicine explains how aspirin’s mechanism of action may help prevent not just cardiovascular disease, but also colon cancer.

0 comments

IGNITE Network’s Mia Levy participates in NCI summit on health IT policy

The American Journal of Managed Care – Dr. Mia Levy of the Vanderbilt Ingram Cancer Center describes opportunities for the successful dissemination and use of actionable health data for researchers and clinicians alike.

0 comments

Mount Sinai obesity research featured in The New York Times

The New York Times – IGNITE Network’s Dr. Carol Horowitz works to reduce disparities in obesity and diabetes in underserved areas of New York City.

0 comments

University of Florida researcher’s heart beats for pharmacogenomics

Genetic Engineering & Biotechnology News – Dr. Julie Johnson of the UF Health Personalized Medicine Program illuminates how current and future advancements in pharmacogenomic research can lead to additional improvements in the treatment of cardiovascular disease.

0 comments

UF Health Personalized Medicine Program featured in GATORx

The UF College of Pharmacy and UF Health Personalized Medicine Program are studying the enzyme CYP2D6 to help doctors identify the most effective pain medications for patients like Jeff Cruse, a grandfather whose severe back pain was poorly controlled for years before enrolling in the study.

0 comments

Vanderbilt University’s Mia Levy named Komen Scholar

Breast Cancer News – As one of the prestigious Komen Scholars, Dr. Mia Levy will help guide research and advocacy conducted by the Susan G. Komen Foundation.

0 comments

American Association of Colleges of Pharmacy recognizes outstanding work of University of Florida’s Julie Johnson (PDF)

AACP News Release – Dr. Julie Johnson received the 2016 Volwiler Research Achievement Award in recognition of sustained excellence in research and scientific contributions.

0 comments

Inaugural UF Precision Medicine Conference: A ‘pharmacogenomics army of champions’

Pharmacy Times – The University of Florida (UF) College of Pharmacy and the UF Health Personalized Medicine Program (PMP) recently hosted a Precision Medicine Conference and certificate training program for pharmacists in Orlando, Florida.

0 comments

Duke University study emphasizes importance of family history in patient care

Duke Medicine News and Communications – Lead author Lori Orlando, M.D., showcases a Duke University study published in the Journal Genetics in Medicine that exposes both the expected and unexpected benefits of using MeTree, a web-based family health history tool.

0 comments

University of Maryland diabetes research highlighted in Genome

Genome – Toni Pollin and her colleagues at the University of Maryland’s Program in Personalized and Genomic Medicine have recently implemented a survey for people diagnosed with diabetes that is designed to find and diagnose people with other forms of diabetes, such as MODY.

0 comments

NIH researchers identify genomic signature shared by five types of cancer

National Human Genome Research Institute – Researchers have identified a striking signature in tumor DNA that occurs in five different types of cancer. They also found evidence that this methylation signature may be present in many more types of cancer.

0 comments

University of Florida hosts inaugural Precision Medicine Conference in Orlando, FL

University of Florida – The expanding role of pharmacogenomics in clinical medicine and education was the focus of the inaugural Precision Medicine Conference

0 comments

IGNITE research in the spotlight in Florida news story

Business Report of Central North Florida – In the weeks and months after a patient gets a heart stent, blood clots can pose a major threat to recovery. Now, University of Florida Health researchers have found that a quick genetic test can tell doctors early on whether a crucial anti-clotting drug will work

0 comments

IGNITE Network’s Josh Denny appointed to team of precision medicine experts for Obama

National Institutes of Health – A newly created team of experts in precision medicine and large clinical research studies will seek public input from the large and diverse stakeholder community interested in the development of the President’s Precision Medicine Initiative and articulate the vision for building the national participant group for the Initiative.

0 comments

IGNITE newsletter features SPARK Toolbox, network updates

The IGNITE Network’s quarterly newsletter provides timely information on developments within the network with a specific focus on genomic implementation tools available for clinicians, researchers, health educators and patients.

0 comments